Theodore Paul Nicolaides MD
Assistant Professor, Pediatrics, University of California, San Francisco, School of Medicine
Join to View Full Profile
160 E 32nd StFl 3New York, NY 10016
Phone+1 212-263-9959
Dr. Nicolaides is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2004 - 2007
NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004- New York University School of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2003 - 2025
CA State Medical License 2004 - 2019
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas Start of enrollment: 2014 Apr 29
Publications & Presentations
PubMed
- 1 citationsPediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.Shashwat Tripathi, Hinda Najem, Corey Dussold, Sebastian Pacheco, Ruochen Du
The Journal of Clinical Investigation. 2024-08-13 - Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment ofV600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-O...Divya Ramakrishnan, Sarah C Brüningk, Marc von Reppert, Fatima Memon, Nazanin Maleki
AJNR. American Journal of Neuroradiology. 2024-04-08 - 3 citationsSex differences in glioblastoma response to treatment: Impact of MGMT methylation.Gino Cioffi, Kristin A Waite, Mantas Dmukauskas, Michael Glantz, Sonikpreet Aulakh
Neuro-Oncology Advances. 2024-03-01
Press Mentions
- New Mutations Enable Gliomas to Resist Proven Treatment, Study ShowsSeptember 24th, 2021
For Children with Brain Tumors, Next-Generation Sequencing May Lead to Different Diagnoses, Less Toxic Targeted TreatmentsNovember 16th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
